{"id":100649,"date":"2026-09-08T04:00:45","date_gmt":"2026-09-08T08:00:45","guid":{"rendered":"https:\/\/news.utoledo.edu\/?p=100649"},"modified":"2026-09-04T11:28:17","modified_gmt":"2026-09-04T15:28:17","slug":"utoledo-ph-d-student-named-to-acs-future-pharma-innovator-cohort","status":"publish","type":"post","link":"https:\/\/news.utoledo.edu\/index.php\/09_08_2026\/utoledo-ph-d-student-named-to-acs-future-pharma-innovator-cohort","title":{"rendered":"UToledo Ph.D. Student Named to ACS Future Pharma Innovator Cohort"},"content":{"rendered":"<p>Trust Nwaka, a Ph.D. student in the Department of Medicinal and Biological Chemistry at The University of Toledo College of Pharmacy and Pharmaceutical Sciences, has been selected as a member of the 2026 American Chemical Society (ACS) Future Pharma Innovator Cohort. He is one of only 22 Ph.D. candidates chosen from the United States and Canada for the highly competitive program.<\/p>\n<div id=\"attachment_100651\" style=\"width: 460px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-100651\" class=\"wp-image-100651 size-full\" src=\"https:\/\/news.utoledo.edu\/wp-content\/uploads\/2026\/09\/Trust-Nwaka-story.jpg\" alt=\"Portrait of Trust Nwaka in a lab. He was one of only 22 Ph.D. candidates from the U.S. and Canada selected as a member of the 2026 American Chemical Society (ACS) Future Pharma Innovator Cohort.\" width=\"450\" height=\"600\" srcset=\"https:\/\/news.utoledo.edu\/wp-content\/uploads\/2026\/09\/Trust-Nwaka-story.jpg 450w, https:\/\/news.utoledo.edu\/wp-content\/uploads\/2026\/09\/Trust-Nwaka-story-225x300.jpg 225w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><p id=\"caption-attachment-100651\" class=\"wp-caption-text\">Trust Nwaka, a Ph.D. student in the Department of Medicinal and Biological Chemistry, has been selected as a member of the 2026 American Chemical Society Future Pharma Innovator Cohort.<\/p><\/div>\n<p>The ACS Future Pharma Innovator program recognizes exceptional emerging scholars who demonstrate strong technical achievement and a commitment to advancing careers in the pharmaceutical industry. Selection into the program is a mark of distinction, identifying participants as among the most promising young researchers in the field.<\/p>\n<p>As a member of the 2026 cohort, Nwaka attended the ACS Fall 2026 Meeting, held Aug. 23-27 in Chicago. During the meeting, cohort members presented their research, engaged in scientific discussions and participated in networking opportunities with peers and industry professionals.<\/p>\n<p><strong>\u00a0<\/strong>\u201cI am very honored to be selected as one of the awardees of the ACS Future Pharma Innovator 2026\u00a0cohort,\u201d Nwaka said. \u201cI am deeply grateful to my advisor, Dr. Schiefer, for his continued support and mentorship, and to The University of Toledo for providing an excellent environment that has allowed me to pursue innovative research, grow as a scientist and reach this important milestone.\u201d<\/p>\n<p>The award also reflects the strength of graduate research at The University of Toledo and the growing impact of its students in addressing global challenges in healthcare and drug development. Programs such as the ACS Future Pharma Innovator initiative help bridge academic research and industry application, preparing the next generation of leaders in pharmaceutical sciences.<\/p>\n<p>Through participation in the cohort, Nwaka joins a national network of scholars and professionals dedicated to advancing innovation, collaboration and excellence in pharmaceutical research.<\/p>\n","protected":false},"excerpt":{"rendered":"<a href=\"https:\/\/news.utoledo.edu\/index.php\/09_08_2026\/utoledo-ph-d-student-named-to-acs-future-pharma-innovator-cohort\"><img width=\"120\" height=\"120\" src=\"https:\/\/news.utoledo.edu\/wp-content\/uploads\/2026\/09\/Trust-Nwaka-main-150x150.jpg\" class=\"alignright tfe wp-post-image\" alt=\"Portrait of Trust Nwaka in a lab. He was one of only 22 Ph.D. candidates from the U.S. and Canada selected as a member of the 2026 American Chemical Society (ACS) Future Pharma Innovator Cohort.\" decoding=\"async\" loading=\"lazy\" \/><\/a><p>Trust Nwaka was one of only 22 Ph.D. candidates from the U.S. and Canada selected for the competitive program, which brought him to the ACS Fall 2026 Meeting in Chicago.<\/p>\n","protected":false},"author":878,"featured_media":100650,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50,95,1,42,7],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/posts\/100649"}],"collection":[{"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/users\/878"}],"replies":[{"embeddable":true,"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/comments?post=100649"}],"version-history":[{"count":5,"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/posts\/100649\/revisions"}],"predecessor-version":[{"id":100656,"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/posts\/100649\/revisions\/100656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/media\/100650"}],"wp:attachment":[{"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/media?parent=100649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/categories?post=100649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.utoledo.edu\/index.php\/wp-json\/wp\/v2\/tags?post=100649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}